Merck sues US government to halt Medicare drug price negotiation Reuters

NEW YORK, June 6 (Reuters) – Merck & Co (MRK.N) sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), wh… [+3847 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *